Trials / Completed
CompletedNCT05126407
A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
A Non-Interventional Clinical Study to Assess the Risk and Performance Aspects of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI) · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.
Conditions
Timeline
- Start date
- 2021-12-17
- Primary completion
- 2022-01-20
- Completion
- 2022-01-20
- First posted
- 2021-11-19
- Last updated
- 2023-02-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05126407. Inclusion in this directory is not an endorsement.